Kevin will provide a quick overview, along with an update on each of our business segments and their respective markets. Then David will review the consolidated results before turning it back over to ...
Throughout the year, we saw robust net product sales revenue growth, steady prescription growth, and strong market share growth across all of our approved indications and formulations of XEREVE, or ...
Matt McAlear explains why former Stellantis CEO’s resignation restores flexibility, if not obscenity “Nobody realized they needed a V10 American supercar when the Viper came out,” chuckles Dodge CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results